Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

R&D Expense Growth

-2.70%

Quarterly · Period ending:

BIO logo

BIO R&D Expense Growth

Latest reported-2.70%
BIO Quarterly R&D Growth (QoQ) (0.00% → -2.70%)
High-resolution chart · PNG

BIO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-3.9451%
11.5699%
0.8857%
-5.7998%
-2.7475%
-4.9415%
70.9091%
0.9174%
3.8095%
-0.9434%
3.9216%
-3.7736%
7.0707%
-24.4275%
19.0909%
-1.7857%
3.7037%
1.8868%
9.2784%
1.0417%
0%
3.2258%
9.4118%
0%
1.1905%
1.2048%
13.6986%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.